Community Support Program for Lung Cancer Screening

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Abramson Cancer Center at Penn Medicine
Study ID
NCT06207435
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Accepted

Interventions

  • Transportation — BEHAVIORAL
    Eligible patients are contacted and offered free transportation to and from their upcoming appointment.

Study Details

The research study aims to create a program for lung cancer screening attendance

Key Dates

Start date
Feb 10, 2023
Status verified
Aug 2025
Primary completion
Aug 12, 2024
Completion
Aug 30, 2024

Study Design

Enrollment
242 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: West Philadelphia Residents
    For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions
  • No Intervention: Non West Philadelphia Residents
    For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.

Primary Outcome Measure

Percentage of Scheduled Lung Cancer Screening Appointments Attended by Participants [ Time Frame: 12 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of PennsylvaniaPhiladelphiaPennsylvania19104-

Find similar trials in Philadelphia, PA

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
University of Pennsylvania· Philadelphia, PA

Related Studies